The protective effect of JZL184 on ovarian ischemia reperfusion injury and ovarian reserve in rats.
Melike Demir ÇaltekinMahmud Mustafa Özkutİbrahim ÇaltekinEmin KaymakMurat ÇakırMustafa KaraEthem Serdar YalvaçPublished in: The journal of obstetrics and gynaecology research (2021)
JZL184 showed significant ameliorative effects on ovarian IRI and ovarian reserve caused by IR through acting as an antioxidant, anti-inflammatory, and antiapoptotic agent. Thus, JZL184 may be a novel therapeutic agent for ovarian IRI.